Industry News Sponsored by
Amyris, Inc. (Emeryville, California) announced it has entered into an agreement with Givaudan (Vernier, Switzerland) in which Givaudan will develop a derivative of Biofene to be used as a building block for proprietary fragrance ingredients in Givaudan’s palette. Biofene is the chemical farnesene, produced using Amyris’s bio-based technology and production platform.
Upon successful achievement of certain success criteria, Amyris will supply Biofene to Givaudan to derive a proprietary fragrance ingredient for the global fragrances and flavors market. Givaudan intends to market and distribute the final product as early as 2012, and Amyris will share in the economic value created from the use of Biofene.